Maria Claudia dos Santos Luciano

Prof. Dr. Maria Claudia dos Santos Luciano


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2019 in Epigenetics
Verified
Journal Article
Closed access
CFCristiana Libardi Miranda Furtado
Cristiana Libardi Miranda Furtado
MLMaria Claudia dos Santos Luciano
Maria Claudia dos Santos Luciano
RSRenan Da Silva Santos
Renan Da Silva Santos
GFGilvan Pessoa Furtado
Gilvan Pessoa Furtado
MMManoel Odorico Moraes
Manoel Odorico Moraes
CPClaudia Pessoa
Claudia Pessoa
Growing evidence suggests that aberrant epigenetic regulation of gene function is strongly related to the genesis of cancer. Unlike genetic mutations, the ability to reprogram the epigenetic landscape in the cancer epigenome is one of the most promising target therapies in both treatment and reversibility of drug resistance. Epigenetic alterations in cancer development and progression may be the basis for the individual variation in drug response. Thus, this review focuses on the emerging area of pharmaco(epi)genomics, specifically highlighting epigenetic reprogramming during tumorigenesis and how epigenetic markers are targeted as a therapy (epidrugs) and the clinical implications of this for cancer treatment.

1 November 2011 in Experimental Parasitology
Verified
Journal Article
Closed access
DBDiana R. Bezerra-Vasconcelos
Diana R. Bezerra-Vasconcelos
LMLuciana M. Melo
Luciana M. Melo
ÉAÉrica S. Albuquerque
Érica S. Albuquerque
MLMaria Claudia dos Santos Luciano
Maria Claudia dos Santos Luciano
CBClaudia M.L. Bevilaqua
Claudia M.L. Bevilaqua

23 March 2017 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
LCLaura N. F. Cardoso
Laura N. F. Cardoso
TNThais C. M. Nogueira
Thais C. M. Nogueira
FRFelipe Rodrigues
Felipe Rodrigues
AOAugusto Cesar Aragão Oliveira
Augusto Cesar Aragão Oliveira
MLMaria Claudia dos Santos Luciano
Maria Claudia dos Santos Luciano
MSMarcos De Souza
Marcos De Souza

8 January 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JMJoão De Miranda
João De Miranda
CMConceição da Silva Martins
Conceição da Silva Martins
LFLazaro de Sousa Fideles
Lazaro de Sousa Fideles
MBMaria Lucianny Lima Barbosa
Maria Lucianny Lima Barbosa
JBJoão Erivan Façanha Barreto
João Erivan Façanha Barreto
GCGilberto Santos Cerqueira
Gilberto Santos Cerqueira
Intestinal mucositis is a common complication associated with 5-fluorouracil (5-FU), a chemotherapeutic agent used for cancer treatment. Troxerutin (TRX), a semi-synthetic flavonoid extracted from Dimorphandra gardneriana, has been reported as a potent antioxidant and anti-inflammatory agent. In the present study, we aimed to evaluate the effect of TRX on 5-FU-induced intestinal mucositis. Swiss mice were randomly divided into seven groups: Saline, 5-FU, TRX-50, TRX-100, TRX-150, Celecoxib (CLX), and CLX + TRX-100. The weight of mice was measured daily. After treatment, the animals were euthanized and segments of the small intestine were collected to evaluate histopathological alterations (morphometric analysis), levels of malondialdehyde (MDA), myeloperoxidase (MPO), glutathione (GSH), mast and goblet cell counts, immunohistochemical analysis, and cyclooxygenase-2 (COX-2) activity. Compared to the saline treatment, the 5-FU treatment induced intense weight loss and reduction in villus height. TRX treatment (100 mg/kg) prevented the 5-FU-induced histopathological changes and decreased oxidative stress by decreasing the MDA levels and increasing GSH concentration. TRX attenuated inflammatory process by decreasing MPO activity, intestinal mastocytosis, and COX-2 expression. TRX also reversed the depletion of goblet cells. Our findings suggest that TRX at a concentration of 100 mg/kg had chemopreventive effects on 5-FU-induced intestinal mucositis via COX-2 pathway.

18 November 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
GBGabriele de Abreu Barreto
Gabriele de Abreu Barreto
JCJamile Costa Cerqueira
Jamile Costa Cerqueira
JRJoão Henrique de Oliveira Reis
João Henrique de Oliveira Reis
KHKatharine Valéria Saraiva Hodel
Katharine Valéria Saraiva Hodel
LGLetícia Amaral Gama
Letícia Amaral Gama
Bruna MachadoBruna Machado
Bruna Machado
The optimized extraction process of natural matrices such as propolis that results in extracts with significant compounds has been one of the main needs of the industry. The aim of this work was to analyze the content of the active components of Brazilian red propolis extracts previously treated with ultrasound, as well as to evaluate in vitro their performance regarding antioxidant capacity and against bacteria and tumor cells. The results of the chromatographic analysis showed the influence of ultrasound treatment for higher yields of formononetin and kaempferol. However, just a higher content of these two components was not enough to interfere with higher concentrations of phenolic compounds and flavonoids among the extracts. The ten extracts obtained showed activity against two bacterial strains, and eight of them showed >70% cytotoxicity against five neoplastic cell lines. These results demonstrated the influence of ultrasound technology as a pretreatment in obtaining the ethanolic extracts of propolis, increasing the possibility of the applicability of Brazilian red propolis in different areas.

1 January 2023 in Animal Reproduction
Verified
Journal Article
Open access
LRLuanna Lorenna Vieira Rodrigues
Luanna Lorenna Vieira Rodrigues
YMYasmin Beatriz França Moura
Yasmin Beatriz França Moura
JVJoão Vitor da Silva Viana
João Vitor da Silva Viana
LOLhara Ricarliany Medeiros de Oliveira
Lhara Ricarliany Medeiros de Oliveira
ÉPÉrika Almeida Praxedes
Érika Almeida Praxedes
APAlexsandra Fernandes Pereira
Alexsandra Fernandes Pereira
The puma population is constantly decreasing, and cloning by somatic cell nuclear transfer can be used to conserve the species. One of the factors determining the success of the development of cloned embryos is the cell cycle stage of the donor cells. We evaluated the effects of full confluency (~100%), serum starvation (0.5% serum), and roscovitine (15 µM) treatments on the cell cycle synchronization in G0/G1 of puma skin-derived fibroblasts by flow cytometric analysis. Also, we assessed the effects of these synchronization methods on morphology, viability, and apoptosis levels using microscopy tools. The results showed that culturing the cells to confluence for 24 h (84.0%), 48 h (84.6%), and 72 h (84.2%) and serum starvation for 96 h (85.4%) yielded a significantly higher percentage of cells arrested in the G0/G1 (P 0.05) phase than cells not subjected to any cell cycle synchronization method (73.9%). Nevertheless, while serum starvation reduced the percentage of viable cells, no difference was observed for the full confluence and roscovitine treatments (P 0.05). Moreover, roscovitine for 12 h (78.6%) and 24 h (82.1%) was unable to synchronize cells in G0/G1 (P 0.05). In summary, full confluency induces puma fibroblast cell cycle synchronization at the G0/G1 stage without affecting cell viability. These outcomes may be valuable for planning donor cells for somatic cell nuclear transfer in pumas.